Search by Drug Name or NDC

    NDC 00169-2030-11 SOGROYA 6.7 mg/mL Details

    SOGROYA 6.7 mg/mL

    SOGROYA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SOMAPACITAN.

    Product Information

    NDC 00169-2030
    Product ID 0169-2030_49f6746f-c935-45c4-af35-02df5db71e87
    Associated GPIs
    GCN Sequence Number 081477
    GCN Sequence Number Description somapacitan-beco PEN INJCTR 10MG/1.5ML SUBCUT
    HIC3 P1A
    HIC3 Description GROWTH HORMONES
    GCN 48603
    HICL Sequence Number 046831
    HICL Sequence Number Description SOMAPACITAN-BECO
    Brand/Generic Brand
    Proprietary Name SOGROYA
    Proprietary Name Suffix n/a
    Non-Proprietary Name somapacitan-beco
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 6.7
    Active Ingredient Units mg/mL
    Substance Name SOMAPACITAN
    Labeler Name Novo Nordisk
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761156
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-2030-11 (00169203011)

    NDC Package Code 0169-2030-11
    Billing NDC 00169203011
    Package 1 SYRINGE, PLASTIC in 1 CARTON (0169-2030-11) / 1.5 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2023-05-01
    NDC Exclude Flag N
    Pricing Information N/A